Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG).
Lukovic J, Moore AJ, Lee MT, Willis D, Ahmed S, Akra M, Hortobagyi E, Kron T, Lim Joon D, Liu A, Ryan J, Thomas M, Wall K, Ward I, Wiltshire KL, O'Callaghan CJ, Wong RKS, Ringash JG, Haustermans K, Leong T. Lukovic J, et al. Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1096-1106. doi: 10.1016/j.ijrobp.2023.06.011. Epub 2023 Jun 29. Int J Radiat Oncol Biol Phys. 2023. PMID: 37393022 Clinical Trial.
Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis.
Thomas M, Borggreve AS, van Rossum PSN, Perneel C, Moons J, Van Daele E, van Hillegersberg R, Deng W, Pattyn P, Mook S, Boterberg T, Ruurda JP, Nafteux P, Lin SH, Haustermans K. Thomas M, et al. Acta Oncol. 2019 Oct;58(10):1358-1365. doi: 10.1080/0284186X.2019.1646432. Epub 2019 Aug 21. Acta Oncol. 2019. PMID: 31432736
PET imaging in adaptive radiotherapy of gastrointestinal tumors.
Bulens P, Thomas M, Deroose CM, Haustermans K. Bulens P, et al. Q J Nucl Med Mol Imaging. 2018 Dec;62(4):385-403. doi: 10.23736/S1824-4785.18.03081-9. Epub 2018 Jun 4. Q J Nucl Med Mol Imaging. 2018. PMID: 29869484 Free article. Review.
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres.
Hoffmann L, Mortensen H, Shamshad M, Berbee M, Bizzocchi N, Bütof R, Canters R, Defraene G, Ehmsen ML, Fiorini F, Haustermans K, Hulley R, Korevaar EW, Clarke M, Makocki S, Muijs CT, Murray L, Nicholas O, Nordsmark M, Radhakrishna G, Thomas M, Troost EGC, Vilches-Freixas G, Visser S, Weber DC, Møller DS. Hoffmann L, et al. Radiother Oncol. 2022 Jul;172:32-41. doi: 10.1016/j.radonc.2022.04.029. Epub 2022 May 2. Radiother Oncol. 2022. PMID: 35513132 Free article. Clinical Trial.
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer.
Thomas M, Mortensen HR, Hoffmann L, Møller DS, Troost EGC, Muijs CT, Berbee M, Bütof R, Nicholas O, Radhakrishna G, Defraene G, Nafteux P, Nordsmark M, Haustermans K. Thomas M, et al. Radiother Oncol. 2021 Mar;156:102-112. doi: 10.1016/j.radonc.2020.11.032. Epub 2020 Dec 5. Radiother Oncol. 2021. PMID: 33285194
187 results